Alert..sold remaining 25% of PCRX at ($11.00) in pre-mkt. Exparel label Here is the label to download. Not a particularly strong label or conference call. http://bit.ly/utIWQM
Exparel label notes a decrease in use of opioids. States that a clinical benefit was not demonstrated. Not the great news they were waiting to hear. Now that this is approved getting sales will be tough to get. They are starting with plastic surgeons & their use in breast augmentation. That is a good cash business.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.